Description

Hyoscyamine Hydrobromide USP

Hyoscyamine Hydrobromide USP is a high-purity, pharmaceutical-grade anticholinergic agent used to treat gastrointestinal, urinary, and neurological disorders involving smooth muscle spasms, secretory imbalances, and functional irritable states. As a salt form of the levorotatory isomer of atropine, Hyoscyamine Hydrobromide provides rapid, potent antispasmodic activity across multiple organ systems. Hyoscyamine Hydrobromide

• Is a USP-compliant salt of levo-hyoscyamine with strong anticholinergic properties
• Is used in oral and sublingual dosage forms for GI disorders, Parkinsonism, and bladder dysfunction
• Acts as a smooth muscle relaxant, antisecretory, and CNS modulator
• Suitable for tablets, elixirs, sublingual preparations, and compounding bases
• Is manufactured under Good Manufacturing Practice (GMP) conditions
• Is supplied with complete regulatory documentation including Certificate of Analysis (CoA) and supporting technical data

Hyoscyamine Hydrobromide is the hydrobromide salt of (S)-Hyoscyamine, a Tropane alkaloid that blocks muscarinic acetylcholine receptors. It reduces spasms in smooth muscle, decreases secretions in the gastrointestinal and respiratory tracts, and may modulate neurological function in certain motor disorders.

In pharmaceutical formulations, Hyoscyamine Hydrobromide USP is used in:

• Irritable bowel syndrome (IBS) and spastic colon treatments
• Bladder and urinary tract antispasmodics in overactive bladder and enuresis
• Parkinsonism adjunct therapy to reduce tremors and rigidity
• Peptic ulcer management as a gastric secretion inhibitor
• Compounded sublingual and liquid medications for rapid onset in neurological or gastrointestinal care

Its rapid absorption and short half-life make Hyoscyamine Hydrobromide ideal for sublingual or oral-dispersible tablet formulations where fast relief is essential.

CarboMer supplies Hyoscyamine Hydrobromide USP with strict controls over chiral purity, heavy metals, residual solvents and microbial content. The material meets United States Pharmacopeia (USP) monograph standards and is suitable for regulated drug manufacturing.

The material is packaged in sealed, tamper-evident, light- and moisture-protective containers. Available in clinical, pilot, and commercial volumes. Minimum order quantities (MOQ), lead times, and full technical documentation—including CoA and SDS—are available upon request.

Each batch is tested for identity (IR, HPLC), assay, optical rotation, loss on drying, heavy metals, and microbial purity. Certificates of Analysis (CoA), Safety Data Sheets (SDS), and full traceability documentation accompany every shipment.

As with all CarboMer anticholinergic APIs, Hyoscyamine Hydrobromide USP is supported by formulation expertise, regulatory compliance support, and secure global sourcing to help bring fast-acting, precision-targeted therapies to market.